Skip to main content

Nutritional Agents with Anti-lnflammatory Properties in Chemoprevention of Colorectal Neoplasia

  • Chapter
  • First Online:
Prospects for Chemoprevention of Colorectal Neoplasia

Part of the book series: Recent Results in Cancer Research ((RECENTCANCER,volume 191))

Abstract

The strong link between inflammation and colorectal carcinogenesis provides the rationale for using anti-inflammatory agents for chemoprevention of colorectal cancer (CRC). Several naturally occurring substances with anti-inflammatory properties, used in a purified ‘nutraceutical’ form, including omega-3 polyunsaturated fatty acids (PUFAs) such as eicosapentaenoic acid (EPA) and polyphenols such as curcumin and resveratrol, have been demonstrated to have anti-CRC activity in preclinical models. As expected, these agents have an excellent safety and tolerability profile in Phase II clinical trials. Phase III randomized clinical trials of these naturally occurring substances are now beginning to be reported. The omega-3 polyunsaturated fatty acid EPA, in the free fatty acid (FFA) form, has been demonstrated to reduce adenomatous polyp number and size in patients with familial adenomatous polyposis (FAP), a finding which has prompted evaluation of this formulation of EPA for prevention of ‘sporadic’ colorectal neoplasia. Anti-inflammatory ‘nutraceuticals’ require further clinical evaluation in polyp prevention trials as they exhibit many of the characteristics of the ideal cancer chemoprevention agent, including safety, tolerability and patient acceptability.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 89.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  • Aggarwal BB, Sundaram C, Malani N et al (2007) Curcumin: the Indian solid gold. Adv Exp Med Biol 595:1–75

    Article  PubMed  Google Scholar 

  • Akedo I, Ishikawa H, Nakamura T et al (1998) Three cases with familial adenomatous polyposis diagnosed as having malignant lesions in the course of a long-term trial using docosahexaenoic acid (DHA)-concentrated fish oil capsules. Jpn J Clin Oncol 28:762–765

    Article  CAS  PubMed  Google Scholar 

  • Balkwill F, Mantovani A (2010) Cancer and inflammation: implications for pharmacology and therapeutics. Clin Pharmacol Ther 87:401–406

    Article  CAS  PubMed  Google Scholar 

  • Ben-Neriah Y, Karin M (2011) Inflammation meets cancer, with NFκB as the matchmaker. Nature Immunol 12:715–723

    Article  CAS  Google Scholar 

  • Bhangle S, Kolasinski SL (2011) Fish oil in rheumatic diseases. Rheum Dis Clin North Am 37:77–84

    Article  PubMed  Google Scholar 

  • Billerey-Larmonier C, Uno JK, Larmonier N et al (2008) Protective effects of dietary curcumin in mouse model of chemically induced colitis are strain dependent. Inflamm Bowel Dis 14:780–793

    Article  PubMed  Google Scholar 

  • Calviello G, Serini S, Piccioni E (2007) n-3 polyunsaturated fatty acids and the prevention of colorectal cancer: molecular mechanisms involved. Curr Med Chem 14:3059–3069

    Article  CAS  PubMed  Google Scholar 

  • Carroll RE, Benya RV, Turgeon DK et al (2011) Phase IIa clinical trial of curcumin for the prevention of colorectal neoplasia. Cancer Prev Res 4:354–364

    Article  CAS  Google Scholar 

  • Chapkin RS, McMurray DN, Lupton JR (2007) Colon cancer, fatty acids and anti-inflammatory compounds. Curr Opin Gastroenterol 23:48–54

    Article  CAS  PubMed  Google Scholar 

  • Chow HH, Hakim IA (2011) Pharmacokinetic and chemoprevention studies on tea in humans. Pharmacol Res 64:105–112

    CAS  PubMed  Google Scholar 

  • Churchill M, Chadburn A, Bilinski RT et al (2000) Inhibition of intestinal tumors by curcumin is associated with changes in the intestinal immune cell profile. J Surg Res 89:166–175

    Article  Google Scholar 

  • Cockbain AJ, Toogood GJ, Hull MA (2011) Omega-3 polyunsaturated fatty acids for the prevention and treatment of colorectal cancer. Gut. doi:10.1136/gut.2010.233718

    PubMed  Google Scholar 

  • Cruz-Correa M, Shoskes DA, Sanchez P (2006) Combination treatment with curcumin and quercetin of adenomas in familial adenomatous polyposis. Clin Gastroenterol Hepatol 4:1035–1038

    Article  CAS  PubMed  Google Scholar 

  • Cui X, Jin Y, Hofseth AB et al (2010) Resveratrol suppresses colitis and colon cancer associated with colitis. Cancer Prev Res 3:549–559

    Article  CAS  Google Scholar 

  • De Caterina R (2011) n-3 fatty acids in cardiovascular disease. N Engl J Med 364:2439–2450

    Article  PubMed  Google Scholar 

  • Dhillon N, Aggarwal BB, Newman RA et al (2008) Phase II trial of curcumin in patients with advanced pancreatic cancer. Clin Cancer Res 14:4491–4499

    Article  CAS  PubMed  Google Scholar 

  • Fichera A, Little N, Dougherty U et al (2007) A vitamin D analogue inhibits colonic carcinogenesis in the AOM/DSS model. J Surg Res 142:239–245

    Article  CAS  PubMed  Google Scholar 

  • Fini L, Piazzi G, Ceccarelli C et al (2010) Highly purified eicosapentaenoic acid as free fatty acids strongly suppresses polyps in ApcMin/+ mice. Clin Cancer Res 16:5703–5711

    Article  CAS  PubMed  Google Scholar 

  • Fini L, Piazzi G, Daoud Y et al (2011) Chemoprevention of intestinal polyps in ApcMin/+ mice fed with western or balanced diets by drinking annurca apple polyphenol extract. Cancer Prev Res 4:907–915

    Article  CAS  Google Scholar 

  • Garcea G, Berry DP, Jones DJ et al (2005) Consumption of the putative chemopreventive agent curcumin by cancer patients: assessment of curcumin levels in the colorectum and their pharmacodynamic consequences. Cancer Epidemiol Biomarkers Prev 14:120–125

    CAS  PubMed  Google Scholar 

  • Hanai H, Sugimoto K (2009) Curcumin has bright prospects for the treatment of inflammatory bowel disease. Curr Pharm Des 15:2087–2094

    Article  CAS  PubMed  Google Scholar 

  • Huang M-T, Lou Y-R, Ma W et al (1994) Inhibitory effects of dietary curcumin on forestomach, duodenal, and colon carcinogenesis in mice. Cancer Res 54:5841–5847

    CAS  PubMed  Google Scholar 

  • Huerta S, Irwin RW, Heber D et al (2002) 1α, 25-(OH)2-D3 and its synthetic analogue decrease tumour load in the ApcMin mouse. Cancer Res 62:741–746

    CAS  PubMed  Google Scholar 

  • Irving GR, Karmokar A, Berry DP et al (2011) Curcumin: the potential for efficacy in gastrointestinal diseases. Best Pract Res Clin Gastroenterol 25:519−534

    Article  CAS  PubMed  Google Scholar 

  • Kalra EK (2003) Nutraceutical––definition and introduction. AAPS J 5:25

    Google Scholar 

  • Klampfer L (2011) Cytokines, inflammation and colon cancer. Curr Cancer Drug Targets 11:451–464

    Article  CAS  PubMed  Google Scholar 

  • Krishnan AV, Feldman D (2011) Mechanisms of the anti-cancer and anti-inflammatory actions of vitamin D. Annu Rev Pharmacol Toxicol 51:311–336

    Article  CAS  PubMed  Google Scholar 

  • MacLean CH, Newberry SJ, Mojica WA et al (2006) Effects of omega-3 fatty acids on cancer risk. A systematic review. J Am Med Assoc 295:403–415

    Article  CAS  Google Scholar 

  • Oh DY, Talukdar S, Bae EJ et al (2010) GPR120 is an omega-3 fatty acid receptor mediating potent anti-inflammatory and insulin-sensitizing effects. Cell 142:687–698

    Article  CAS  PubMed  Google Scholar 

  • Patel VB, Misra S, Patel BB et al (2010) Colorectal cancer: chemopreventive role of curcumin and resveratrol. Nutr Cancer 62:958–967

    Article  CAS  PubMed  Google Scholar 

  • Pereira MA, Grubbs CJ, Barnes LH et al (1996) Effects of the phytochemicals, curcumin and quercetin, upon azoxymethane-induced colon cancer and 7,12-dimethylbenz[a]anthracene-induced mammary cancer in rats. Carcinogenesis 17:1305–1311

    Article  CAS  PubMed  Google Scholar 

  • Perkins S, Verschoyle RD, Hill K et al (2002) Chemopreventive efficacy and pharmacokinetics of curcumin in the Min/+ mouse, a model of familial adenomatous polyposis. Cancer Epidemiol Biomarkers Prev 11:535–540

    CAS  PubMed  Google Scholar 

  • Ponnurangam S, Mondalek FG, Govind J et al (2010) Urine and serum analysis of consumed curcuminoids using an IkappaB-luciferase surrogate marker assay. In vivo 24:861–864

    PubMed  Google Scholar 

  • Popovinova BK, Kostadinova FI, Furuichi K et al (2009) Blockade of a chemokine, CCL2, reduces chronic colitis-associated carcinogenesis. Cancer Res 69:7884–7892

    Article  Google Scholar 

  • Rao CV, Rivenson A, Simi B, Reddy BS (1995) Chemoprevention of colon carcinogenesis by dietary curcumin, a naturally occurring plant phenolic compound. Cancer Res 55:259–266

    CAS  PubMed  Google Scholar 

  • Ricciardiello L, Bazzoli F, Fogliano V (2011) Phytochemicals and colorectal cancer prevention-myth or reality? Nature Rev Gastroenterol Hepatol 8:592–596

    Article  CAS  Google Scholar 

  • Sanchez-Fidalgo S, Cardeno A, Villegas I et al (2010) Dietary supplementation of resveratrol attenuates chronic colonic inflammation in mice. Eur J Pharmacol 633:78–84

    Article  CAS  PubMed  Google Scholar 

  • Sanders LM, Henderson CE, Hong MY et al (2004) An increase in reactive oxygen species by dietary fish oil coupled with the attenuation of antioxidant defenses by dietary pectin enhances rat colonocyte apoptosis. J Nutr 134:3233–3238

    CAS  PubMed  Google Scholar 

  • Schley PD, Brindley DN, Field CJ (2007) n-3 PUFA alter raft lipid composition and decrease epidermal growth factor receptor levels in lipid rafts of human breast cancer cells. J Nutr 137:548–553

    CAS  PubMed  Google Scholar 

  • Schneider Y, Duranton B, Gosse F et al (2001) Resveratrol inhibits intestinal tumorigenesis and modulates host-defense-related gene expression in an animal model of human familial adenomatous polyposis. Nutr Cancer 39:102–107

    Article  CAS  PubMed  Google Scholar 

  • Serhan CN, Chiang N, van Dyke TE (2008) Resolving inflammation: dual anti-inflammatory and pro-resolution lipid mediators. Nat Rev Immunol 8:349–361

    Article  CAS  PubMed  Google Scholar 

  • Shimizu M, Fukutomi Y, Ninomiya M et al (2008) Green tea extracts for the prevention of metachronous colorectal adenomas: a pilot study. Cancer Epidemiol Biomarkers Prev 17:3020–3025

    Article  CAS  PubMed  Google Scholar 

  • Smith WL (2005) Cyclooxygenases, peroxide tone and the allure of fish oil. Curr Opin Cell Biol 17:174–182

    Article  CAS  PubMed  Google Scholar 

  • Steinbach G, Lynch PM, Phillips RKS et al (2000) The effect of celecoxib, a cyclooxygenase-2 inhibitor, in familial adenomatous polyposis. N Engl J Med 342:1946–1952

    Article  CAS  PubMed  Google Scholar 

  • Sugimoto K, Hanai H, Tozawa K et al (2002) Curcumin prevents and ameliorates trinitrobenzene sulfonic acid-induced colitis in mice. Gastroenterology 123:1912–1922

    Article  CAS  PubMed  Google Scholar 

  • Tessitore L, Davit A, Sarotto I et al (2000) Resveratrol depresses the growth of colorectal aberrant crypt foci by affecting bax and p21(CIP) expression. Carcinogenesis 21:1619–1622

    Article  CAS  PubMed  Google Scholar 

  • Touvier M, Chan DS, Lau R et al (2011) Meta-analyses of vitamin D intake, 25-hydroxyvitamin D status, vitamin D receptor poymorphisms and colorectal cancer risk. Cancer Epidemiol Biomarkers Prev 20:1003–1016

    Article  CAS  PubMed  Google Scholar 

  • Ullman TA, Itzkowitz SH (2011) Intestinal inflammation and cancer. Gastroenterology 140:1807–1816

    Article  CAS  PubMed  Google Scholar 

  • Vanamala J, Glagolenko A, Yang P et al (2008) Dietary fish oil and pectin enhance colonocyte apoptosis in part through suppression of PPARδ/PGE2 and elevation of PGE3. Carcinogenesis 29:790–796

    Article  CAS  PubMed  Google Scholar 

  • Vecchio AJ, Simmons DM, Malkowski MG (2010) Structural basis of fatty acid substrate binding to cyclooxygenase-2. J Biol Chem 285:22152–22163

    Article  CAS  PubMed  Google Scholar 

  • Vlachojannis J, Magora F, Chrubasik S (2011) Willow species and aspirin: different mechanisms of action. Phytother Res. doi:10.1002/ptr.3386

    PubMed  Google Scholar 

  • Wall R, Ross RP, Fitzgerald GF, Stanton C (2010) Fatty acids from fish: the anti-inflammatory potential of long-chain omega-3 fatty acids. Nutr Rev 68:280–289

    Article  PubMed  Google Scholar 

  • Wang D, DuBois RN (2010) The role of COX-2 in intestinal inflammation and colorectal cancer. Oncogene 29:781–788

    Article  CAS  PubMed  Google Scholar 

  • Weber WM, Hunsaker LA, Abcouwer SF et al (2005) Anti-oxidant activities of curcumin and related enones. Bioorg Med Chem 13:3811–3820

    Article  CAS  PubMed  Google Scholar 

  • West NJ, Belluzzi A, Lund EK et al (2009) Eicosapentaenoic acid (EPA), as the free fatty acid, reduces colonic crypt cell proliferation in patients with sporadic colorectal polyps. Gut 58(Suppl. 2):A68 (abstract)

    Google Scholar 

  • West NJ, Clark SK, Philips RK et al (2010) Eicosapentaenoic acid reduces rectal polyp number and size in familial adenomatous polyposis. Gut 59:918–925

    Article  CAS  PubMed  Google Scholar 

  • World Cancer Research Fund/American Institute for Cancer Research (2007) Food, nutrition, physical activity, and the prevention of cancer: a global perspective. AICR, Washington DC

    Google Scholar 

  • World Cancer Research Fund/American Institute for Cancer Research (2011) Continuous update project interim report summary. Food, nutrition, physical activity, and the prevention of colorectal cancer

    Google Scholar 

  • Zhang X, Giovannucci E (2011) Calcium, vitamin D and colorectal cancer chemoprevention. Best Pract Res Clin Gastroenterol 25:485−494

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgments

Work in the Hull laboratory is funded by the National Institute for Health Research Efficacy & Mechanism Evaluation Programme, Yorkshire Cancer Research and an unrestricted Scientific Grant from SLA Pharma (UK).

Conflict of Interest Statement

Mark Hull has received an unrestricted Scientific Grant and a travel grant for conference travel from SLA Pharma (UK), which produces the ω-3 PUFA EPA, in the free fatty acid form.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Mark A. Hull .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2013 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Hull, M.A. (2013). Nutritional Agents with Anti-lnflammatory Properties in Chemoprevention of Colorectal Neoplasia. In: Chan, A., Detering, E. (eds) Prospects for Chemoprevention of Colorectal Neoplasia. Recent Results in Cancer Research, vol 191. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-30331-9_8

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-30331-9_8

  • Published:

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-30330-2

  • Online ISBN: 978-3-642-30331-9

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics